This study investigates the activity of lipopolysaccharide endotoxins in Gram-negative bacteria using a chemiluminescent assay. The methodology involves the interaction of anti-lipid A antibodies with endotoxins and neutrophils, leading to a measurable immune response.
In Gram-negative bacteria, lipopolysaccharide endotoxins are vital components of the bacterial outer membrane.
Structurally, an endotoxin is comprised of the O-antigen - outermost polysaccharide chain connected via a central core to lipid A, an immunostimulatory glycolipid crucial for endotoxin activity.
To investigate endotoxin activity, take a test tube with a suitable buffer containing anti-lipid A antibodies, zymosan - an exogenous neutrophil activator, and luminol - a chemiluminescent agent.
Suspend an optimum volume of an infected blood sample comprising endotoxins and blood cells, including neutrophils. Incubate the tube under physiological conditions.
During incubation, anti-lipid A antibody recognizes the lipid-A component of the endotoxin and binds to it via antigen-binding domains, resulting in the formation of an antibody-endotoxin complex.
The endotoxin-bound antibody's FC domain binds to the neutrophils' complementary receptor, presenting the attached endotoxins to neutrophils. This binding acts as a priming stimulus for neutrophils, triggering their activation.
Activated neutrophils engulf the zymosan and initiate an immune response, resulting in a rapid release of reactive oxygen species, ROS, from neutrophils. These ROS facilitate luminol oxidation, resulting in light emission by chemiluminescence.
The chemiluminescence signal intensity corresponds to the endotoxin activity in the blood sample.
First, place the EA tubes to be used in tube racks and remove the caps. Use a combi-pipette to transfer 1 milliliter of the EA reagent from the bottle into tubes number 1, number 2, and number 3, by pipetting down the side of the tubes. Gently invert the blood collection tube 20 times to mix the patient's blood sample. Then, pipette 0.5 milliliters of patient blood into tube number 4 and tube number 5. Vortex tube number 4 for 10 seconds.
Place the tube racks with all of the EA test tubes into the incubator shaker, close the lid, and incubate at 37 degrees Celsius for 10 minutes. After this, open the incubator lid, and remove the tube racks from the shaker.
Vortex tube number 5. Using a sterile tip, pipette 40 microliters of blood into tubes number 1 and number 2, in duplicate.
Vortex tube number 4. Using the same pipette tip, transfer 40 microliters of blood from tube number 4 into tube number 3, in duplicate.
Vortex the six final test tubes one by one. Place the tube racks back into the incubating shaker and close the lid. Set the shaker to 100 RPM and start the motion for 14 minutes.
Insert the EA-labeled chip card into the chemiluminometer and press 'Start.' After the 14-minute incubation, follow the instructions displayed on the chemiluminometer. Gently vortex each tube for 10 seconds before placing it onto the sample holder of the chemiluminometer.
Open the sample drawer and place tube number 1 into the sample holder. Then, close the sample drawer and wait for the Relative Light Unit reading. Repeat this reading process for tubes 2 and 3, and all duplicates as outlined in the text protocol.
After all of the tubes have been processed, the EA results will be calculated and printed automatically.
Repeat the entire assay process for each blood sample that needs to be tested. Store the EA assay kit and its components in the original sealed package, at a temperature between 2 and 25 degrees Celsius.